Investment ThemesDetailed Quotes
Cannabis & Hemp
Watchlist
The Cannabis concept includes major US-listed cannabis producers.
- 111.373
- -0.552-0.49%
Close Feb 28 16:00 ET
111.409High109.964Low
110.917Open111.926Pre Close74.12MVolume8RiseLossP/E (Static)307.43MTurnover2Flatline1.77%Turnover Ratio36.56BMarket Cap10Fall34.48BFloat Cap
Constituent Stocks: 20Top Rising: AIM+6.30%
Canopy Growth Establishes New US$200 Million At-The-Market Program
Friday, 28th February at 5:18 pm
Net proceeds expected to be used for corporate purposes including paying down debt, strengthening the Company's cash position, and supporting strategic M&A
SMITHS FALLS, ON, Feb. 28, 2025 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NASDAQ: CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis to...
not a bad average if I say so myself
How Canopy Growth's German Market Entry Could Reshape European Medical Cannabis Landscape
AIM ImmunoTech Announces NYSE American Acceptance of Plan to Regain Listing Compliance
Wednesday, 26th February at 1:20 pm
OCALA, Fla., Feb. 26, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE: AIM) ("AIM" or the "Company") today announced that it received notice from the NYSE American (the "American") that the American has accepted the Company's Plan to regain compliance with the minimum stockholders' equity requirements of Sections 1003(a)(ii) and 1003(a)(iii) o...
👀
Can Teva's Injectable UZEDY Revolutionize Bipolar I Disorder Treatment? FDA Now Reviewing
No comment yet